Showing results (271-280 of 424) with videos related to
Sort By:
Pageof 43
Hepatology (Baltimore, Md.)|January 17, 2020
Cenicriviroc Treatment for Adults With Nonalcoholic Steatohepatitis and Fibrosis: Final Analysis of the Phase 2b CENTAUR StudyVlad Ratziu, Arun Sanyal, Stephen A Harrison, et al.JHEP Reports : Innovation in Hepatology|March 11, 2026
The Elucidating Pathways of Steatohepatitis (EPoS) staging system: A reproducible 7-tiered fibrosis scoring system in MASLDDina G Tiniakos, Pierre Bedossa, Johanna Arola, et al.Cancer|December 12, 2003
Gemcitabine plus oxaliplatin for patients with advanced hepatocellular carcinoma using two different schedulesJulien Taïeb, Luminita Bonyhay, Lamia Golli, et al.Journal of Hepatology|November 5, 2022
Hepatic and renal improvements with FXR agonist vonafexor in individuals with suspected fibrotic NASHVlad Ratziu, Stephen A Harrison, Véronique Loustaud-Ratti, et al.Hepatology (Baltimore, Md.)|July 22, 2014
Portal myofibroblasts promote vascular remodeling underlying cirrhosis formation through the release of microparticlesSara Lemoinne, Axelle Cadoret, Pierre-Emmanuel Rautou, et al.Gastroenterology|October 3, 2002
Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis CJohn G McHutchison, Michael Manns, Keyur Patel, et al.Antiviral Therapy|March 6, 2018
Chronic hepatitis E in a heart transplant patient: sofosbuvir and ribavirin regimen not fully effectiveEve Todesco, Alessandra Mazzola, Sepideh Akhavan, et al.Alimentary Pharmacology & Therapeutics|March 15, 2023
Review article: The need for more efficient and patient-oriented drug development pathways in NASH-setting the scene for platform trialsJuan M Pericàs, Nicholas A Di Prospero, Quentin M Anstee, et al.Clinics and Research in Hepatology and Gastroenterology|January 23, 2020
Input of serum haptoglobin fucosylation profile in the diagnosis of hepatocellular carcinoma in patients with non-cirrhotic liver diseaseValentina Peta, Jianhui Zhu, David M Lubman, et al.JHEP Reports : Innovation in Hepatology|April 18, 2022
Metabolic signatures across the full spectrum of non-alcoholic fatty liver diseaseAidan J McGlinchey, Olivier Govaere, Dawei Geng, et al.Pageof 43